Does NATALIZUMAB Cause Blindness transient? 101 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Blindness transient have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.2% of all adverse event reports for NATALIZUMAB.
101
Reports of Blindness transient with NATALIZUMAB
0.2%
of all NATALIZUMAB reports
0
Deaths
24
Hospitalizations
How Dangerous Is Blindness transient From NATALIZUMAB?
Of the 101 reports, 24 (23.8%) required hospitalization.
Is Blindness transient Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 101 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Blindness transient?
AFLIBERCEPT (987)
ADALIMUMAB (200)
METFORMIN (153)
DIMETHYL (119)
INTERFERON BETA-1A (102)
RANIBIZUMAB (100)
BROLUCIZUMAB-DBLL (99)
FINGOLIMOD (89)
BEVACIZUMAB (72)
DUPILUMAB (59)
Which NATALIZUMAB Alternatives Have Lower Blindness transient Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK